R R Strang. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultFemaleHumansMaleParkinson Disease/drug therapyPrognosisPropranololStatistics as TopicSympatholytics/therapeutic use
Substances: See more » SympatholyticsPropranolol
Year: 1965 PMID: 5839555 PMCID: PMC495925 DOI: 10.1136/jnnp.28.5.404
Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN: 0022-3050 Impact factor: 10.154